全文获取类型
收费全文 | 7986篇 |
免费 | 1099篇 |
国内免费 | 3716篇 |
出版年
2024年 | 89篇 |
2023年 | 261篇 |
2022年 | 394篇 |
2021年 | 462篇 |
2020年 | 458篇 |
2019年 | 490篇 |
2018年 | 332篇 |
2017年 | 347篇 |
2016年 | 361篇 |
2015年 | 541篇 |
2014年 | 722篇 |
2013年 | 637篇 |
2012年 | 833篇 |
2011年 | 759篇 |
2010年 | 650篇 |
2009年 | 636篇 |
2008年 | 715篇 |
2007年 | 678篇 |
2006年 | 590篇 |
2005年 | 503篇 |
2004年 | 389篇 |
2003年 | 332篇 |
2002年 | 291篇 |
2001年 | 264篇 |
2000年 | 247篇 |
1999年 | 173篇 |
1998年 | 99篇 |
1997年 | 80篇 |
1996年 | 42篇 |
1995年 | 45篇 |
1994年 | 31篇 |
1993年 | 20篇 |
1992年 | 22篇 |
1991年 | 29篇 |
1990年 | 32篇 |
1989年 | 32篇 |
1988年 | 17篇 |
1987年 | 14篇 |
1986年 | 25篇 |
1985年 | 13篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 24篇 |
1981年 | 8篇 |
1978年 | 6篇 |
1977年 | 7篇 |
1965年 | 6篇 |
1964年 | 5篇 |
1953年 | 5篇 |
1950年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
中国吻额蛛属一新种(蜘蛛目:皿蛛科:微蛛亚科) 总被引:1,自引:1,他引:0
本文描述了作者1986年采自湖北省神农架林区的吻额蛛属Aprifrontalia一新种:膨大吻额蛛,新种Aprifrontalia afflata sp.nov.。目前,除本新种外,世界仅报道过1种:Aprifrontalia mascula,本新种雄蛛最显著的特征是:其额向前突呈吻状,触肢胫节前端甚膨大。外雌器形成一斜向下方的突起。模式标本保存于白求恩医科大学生物教研室。 相似文献
102.
H. Mercier C. C. J. Vieira R. C. L. Figueiredo-Ribeiro 《Plant Cell, Tissue and Organ Culture》1992,28(3):249-254
Leaf and stem segments of Gomphrena officinalis originated from aseptically grown seedlings were used to initiate cultures. Callus production was obtained on gelled Murashige & Skoog medium supplemented with 6-benzylaminopurine alone (1.0, 5.0 or 10.0 mgl-1) or combined with -naphthalene acetic acid (0.1, 0.5 and 1.0 mgl-1) after 10 to 15 days of culture, and can be transferred to fresh medium every 30 days. The combinations of 5.0 or 10.0 mgl-1 of 6-benzylaminopurine with 0.1 mgl-1 of -naphthalene acetic acid were found to be the best for shoot regeneration. Adventitious shoot formation occurred after 50 to 60 days of culture in leaf and internode stem explants. Nodal segments developed actively growing lateral buds after 30 days of culture. Gelled Murashige & Skoog medium containing 10 mgl-1 of indole-3-butyric acid was considered optimal for the rooting of shoots. Rooted plants transferred to potting soil could be successfully established.Abbreviations BA
6-benzylaminopurine
- IAA
indole-3-acetic acid
- IBA
indole-3-butyric acid
- MS
Murashige & Skoog
- NAA
-naphthalene acetic acid 相似文献
103.
本实验用幼年大鼠经PMSG/hCG诱发排卵,研究了印巢PGE_2、PGF_(2α) 、6-酮-PGF_(1α) 及TXB_2在排卵过程中的变化。实验表明卵巢PGE_2、PGF_(2α) 及6-酮-PGF_(1α) 在排卵前达到峰值,在排卵后,均趋下降。TXB_2未出现明显变化。受试动物经消炎痛处理后,不仅使排卵受到严重抑制,而对上述三种PGs在排卵前的上升也表现了显著的抑制。提示在卵泡破裂过程中PGs的重要调节作用,PGE_2、PGF_(2α)均可能参与排卵,其中尤以PGE_2的作用最为显著。 相似文献
104.
105.
106.
107.
108.
109.
De Moraes DJ Abilio FM Cunha M Feitosa LA Aragão E Cysne E Vieira R Glavam HC Zaniolo W Netto MS Villela RD Labrunie P 《Cardiovascular diseases》1979,6(2):144-152
Thirteen patients were submitted to direct myocardial revascularization (saphenous vein graft) without the use of an artificial oxygenator. The perfusion was done by a left ventricle-to-aorta bypass and autogenous oxygenation. Most patients had three grafts implanted plus endarterectomy of the distal right coronary artery. There was one hospital death that was apparently not related to the method used. Perfusion time ranged from 45 minutes to 4 hours. Body temperature during perfusion was kept between 25 and 30 degrees C. Perfusion flow was maintained between 25 to 50 ml per kg of body weight per minute. Ischemic, hypothermic cardiac arrest was employed. We demonstrated for the first time that perfusion for this kind of heart surgery could be done with no artificial oxygenators and, apparently, is safer for the patients. There were no bleeding problems even in perfusions as long as 4 hours. There was no respiratory dysfunction, and artificial respiration was used for only 6 to 12 hours. The patients awoke at the end of surgery with no signs or symptoms of central nervous system damage, and vasopressor drugs were rarely used after surgery. Although the experience is very small, it suggests that many postoperative problems, especially those related to bleeding and respiratory dysfunction may be reduced or eliminated by this new method. 相似文献
110.
Regenerative medicine is a burgeoning field that is important to combat challenging diseases and functional impairments. Compared with traditional cell therapies with evident shortcomings (e.g., cell suspension injection or tissue engineering with scaffolds), scaffold-free cell sheet technology enables transplanted cells to be grafted and fully maintain their viability on target sites. Clinical and experimental studies have advanced the application of cell sheet technology to numerous tissues and organs (e.g., liver, cornea and bone). However, previous reviews have failed to discuss vital aspects of this rapidly developing technology, and many new challenges are gradually emerging. This review aims to provide a comprehensive introduction to cell sheet technology from cell selection to the ultimate applications of cell sheets, and challenges and future visions are also described. 相似文献